Mesylate[(di(1-adamantyl)-n-butylphosphine)-2-(2'-MeNH-1,1'-biphenyl)]palladium(II)

Catalog No. :
ACOUEG469
CAS No. :
2230788-67-5
Molecular Formula :
-
Molecular Weight :
742.3

IUPAC Name:Mesylate[(di(1-adamantyl)-n-butylphosphine)-2-(2'-MeNH-1,1'-biphenyl)]palladium(II)

Mesylate[(di(1-adamantyl)-n-butylphosphine)-2-(2'-MeNH-1,1'-biphenyl)]palladium(II) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$114.00Login to see priceIn stockInquiry
5g98%$344.00Login to see priceIn stockInquiry
25g98%$982.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMesylate[(di(1-adamantyl)-n-butylphosphine)-2-(2'-MeNH-1,1'-biphenyl)]palladium(II)
IUPAC NameMesylate[(di(1-adamantyl)-n-butylphosphine)-2-(2'-MeNH-1,1'-biphenyl)]palladium(II)
MDL No.MFCD22200553
Molecular Weight742.3
SMILESO=S([O-][Pd+2]1([P](C23CC4CC(C3)CC(C2)C4)(C56CC7CC(C6)CC(C5)C7)CCCC)[C-]8=C(C9=C([NH]1C)C=CC=C9)C=CC=C8)(C)=O
InChI KeyTZXYYOHJYJFGQA-UHFFFAOYSA-M
Synonym[di(adamantan-1-yl)(butyl)phosphine](methanesulfonato-κO)[2′-(methylamino)-2-biphenylyl]palladium
CAS No.2230788-67-5
PubChem CID156595150

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACOUEG469 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOUEG469 route product structure diagram
    ACOUEG4692230788-67-5 In Stock
Inquiry

2. ACOUEG469 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOUEG469 route product structure diagram
    ACOUEG4692230788-67-5 In Stock
Inquiry

Comments (0)